Lv1
40 积分 2024-06-14 加入
T cell-redirecting antibody for treatment of solid tumors via targeting mesothelin
2天前
已完结
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
16天前
已完结
Preclinical safety profile of RC88-ADC：a novel mesothelin-targeted antibody conjugated with Monomethyl auristatin E
24天前
已完结
Mesothelin (MSLN) is Highly Expressed in Triple Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Proinflammatory Tumor Microenvironment
1个月前
已完结
The advent of immune stimulating CAFs in cancer
1个月前
已完结
The role and molecular mechanism of CTHRC1 in fibrosis
1个月前
已完结
Classifying cancer-associated fibroblasts—The good, the bad, and the target
1个月前
已完结
New immune cell engagers for cancer immunotherapy
1个月前
已完结
First muscle-growing antibody heads to the FDA, with obesity opportunities on the horizon
1个月前
已完结
CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15
1个月前
已完结
皖公网安备34019202002308
